Evaluating the prognostic relevance of neutrophil-to-lymphocyte ratio in cervical cancer: a systematic review and meta-analysis
Frontiers in Oncology · 23.12.2024 · 14
DOI: 10.3389/fonc.2024.1461175 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Frontiers in Oncology, online erschienen am 23.12.2024. Verfasst von Xieyan Zhuang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Gynecology Department of Mingzhou Hospital, Ningbo, Zhejiang, China. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Recently, the neutrophil-to-lymphocyte ratio (NLR) has emerged as a promising prognostic marker for survival outcomes in individuals affected cervical cancer. However, research specifically focusing on the prognostic relevance of NLR across different cancer stages and in cases of recurrent metastases remains scant.
Methods
We executed a systematic review of the literature from databases including PubMed, Embase, the Cochrane Library, and Web of Science, covering publications up to March 3, 2024. Studies evaluating the relationship between NLR and patient clinical outcomes were retrieved, guided by specifically defined inclusion and exclusion parameters. The key goals were to assess progression-free survival (PFS) and overall survival (OS), measured through hazard ratios (HR) and 95% confidence intervals (CI).
Results
This meta-analysis encompassed 38 retrospective cohort studies, including data from 10,246 patients. The aggregated data showed that patients with increased NLR prior to treatment exhibit reduced OS (HR = 1.58, 95% CI: 1.44-1.74; p < 0.00001) and decreased PFS (HR = 1.48, 95% CI: 1.34-1.63; p < 0.00001). Furthermore, elevated NLR significantly impacted disease-free survival (HR: 1.79, 95% CI: 1.18-2.71; p = 0.006), recurrence rates (HR: 2.18, 95% CI: 1.36-3.51; p = 0.001), recurrence-free survival (HR: 3.05, 95% CI: 1.79-5.19; p < 0.0001), and the incidence of distant metastases (HR: 1.73, 95% CI: 1.20-2.50; p = 0.003).
Conclusion
An elevated NLR prior to treatment demonstrates a strong association with decreased OS and PFS among patients with cervical cancer, underscoring the significance of NLR as a prognostic marker within this population. Systematic review registration https://www.crd.york.ac.uk/PROSPERO/display_record.php?RecordID=529817 , identifier CRD42024529817.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Gynecology Department of Mingzhou Hospital, Ningbo, Zhejiang, China.
Zitieren
APA
Zhuang, X., Li, Y., Zheng, H., & Fu, L. (2024). Evaluating the prognostic relevance of neutrophil-to-lymphocyte ratio in cervical cancer: a systematic review and meta-analysis. Frontiers in Oncology, 14. https://doi.org/10.3389/fonc.2024.1461175
Vancouver
Zhuang X, Li Y, Zheng H, Fu L. Evaluating the prognostic relevance of neutrophil-to-lymphocyte ratio in cervical cancer: a systematic review and meta-analysis. Frontiers in Oncology. 2024;14. doi:10.3389/fonc.2024.1461175
BibTeX
@article{Zhuang2024,
author = {Zhuang, Xieyan and Li, Yan and Zheng, Hongfeng and Fu, Langjing},
title = {Evaluating the prognostic relevance of neutrophil-to-lymphocyte ratio in cervical cancer: a systematic review and meta-analysis},
journal = {Frontiers in Oncology},
year = {2024},
volume = {14},
doi = {10.3389/fonc.2024.1461175}
}
EUVIMED